These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22124202)
21. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles. Banday AH; Saeed BA; Al-Masoudi NA Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853 [TBL] [Abstract][Full Text] [Related]
22. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation. Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors. Numazawa M; Kamiyama T; Tachibana M; Oshibe M J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367 [TBL] [Abstract][Full Text] [Related]
24. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase. Numazawa M; Yamada K; Kidokoro K Biol Pharm Bull; 1999 Oct; 22(10):1134-6. PubMed ID: 10549872 [TBL] [Abstract][Full Text] [Related]
25. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids. Takahashi M; Yamashita K; Numazawa M Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721 [TBL] [Abstract][Full Text] [Related]
26. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors. Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958 [TBL] [Abstract][Full Text] [Related]
27. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs. Numazawa M; Shelangouski M; Nagasaka M Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors. Lovett JA; Darby MV; Counsell RE J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488 [TBL] [Abstract][Full Text] [Related]
31. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors. Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516 [TBL] [Abstract][Full Text] [Related]
32. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells. Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197 [TBL] [Abstract][Full Text] [Related]
33. Biological aromatization of delta4,6- and delta1,4,6-androgens and their 6-alkyl analogs, potent inhibitors of aromatase. Numazawa M; Yoshimura A J Steroid Biochem Mol Biol; 1999; 70(4-6):189-96. PubMed ID: 10622407 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors. Numazawa M; Yamaguchi S Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379 [TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids. Nagaoka M; Watari Y; Yajima H; Tsukioka K; Muroi Y; Yamada K; Numazawa M Steroids; 2003 Aug; 68(6):533-42. PubMed ID: 12906938 [TBL] [Abstract][Full Text] [Related]
37. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer. Yadav MR; Barmade MA; Tamboli RS; Murumkar PR Eur J Med Chem; 2015 Nov; 105():1-38. PubMed ID: 26469743 [TBL] [Abstract][Full Text] [Related]
38. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase. Numazawa M; Mutsumi A; Hoshi K; Tanaka Y Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774 [TBL] [Abstract][Full Text] [Related]